Rex A, Marsden C A, Fink H
Institute of Pharmacology and Toxicology, Medical Faculty of the Humboldt University at Berlin, Germany.
Neurosci Lett. 1997 Jun 6;228(2):79-82. doi: 10.1016/s0304-3940(97)00371-6.
Serotonin (5-HT) and cholecystokinin (CCK) are involved in the development of anxiety. There are only few data suggesting interactions between CCK and 5-HT under aversive conditions. In our study the cholecystokinin tetrapeptide (CCK-4) (10 microg/kg) induced 'anxious' behaviour and potentiated the increase of 5-HT release on the elevated plus maze (X-maze). The 'anxiolytic' 5-HT1A agonist 8-hydroxy-2-(di-n-propyl amino) tetralin (8-OH-DPAT; 0.3 mg/kg) reduced basal 5-HT and the increase in 5-HT release on the X-maze. 8-OH-DPAT given simultaneously with CCK-4, blocked the effects of CCK-4. The results demonstrate an interaction between CCK and 5-HT1A mechanisms via the influence on cortical 5-HT release.
血清素(5-羟色胺,5-HT)和胆囊收缩素(CCK)与焦虑的形成有关。仅有少量数据表明在厌恶条件下CCK与5-HT之间存在相互作用。在我们的研究中,胆囊收缩素四肽(CCK-4)(10微克/千克)诱发了“焦虑”行为,并增强了高架十字迷宫(X迷宫)上5-HT释放的增加。“抗焦虑”的5-HT1A激动剂8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT;0.3毫克/千克)降低了基础5-HT水平以及X迷宫上5-HT释放的增加。与CCK-4同时给予8-OH-DPAT可阻断CCK-4的作用。结果表明CCK与5-HT1A机制之间通过对皮质5-HT释放的影响而存在相互作用。